Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04218422 · ClinicalTrials.gov registry record · NA

Battlefield Acupuncture for Pain in Hidradenitis Suppurativa

A NA study of Hidradenitis Suppurativa, sponsored by Wayne State University.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT04218422 is a NA study of Hidradenitis Suppurativa that is actively recruiting participants, run by Wayne State University. The registered enrollment target is 32 participants, below the 597-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04218422, a NA study of Hidradenitis Suppurativa, is actively recruiting participants, sponsored by Wayne State University.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The investigators will investigate battlefield acupuncture as a treatment for the pain of hidradenitis suppurativa.

Conditions Studied

Interventions

  • PROCEDURE Sham Acupuncture
  • PROCEDURE Battlefield Acupuncture

Study Locations (1)

Michigan

  • WSUPG Dermatology - Dearborn

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2020-01-22
Est. Completion 2031-02-20
Phase NA

Sponsor

Wayne State University

163 total trials

What the Registry Record Tells You About NCT04218422

The ClinicalTrials.gov registry entry for NCT04218422 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 597-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (95% lower). The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hidradenitis Suppurativa appearing as the primary indexed condition, and to 2 interventions - of which Sham Acupuncture is the first listed.

NCT04218422 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT04218422 about?

NCT04218422 is a clinical study titled "Battlefield Acupuncture for Pain in Hidradenitis Suppurativa". The investigators will investigate battlefield acupuncture as a treatment for the pain of hidradenitis suppurativa.

What is the current status of trial NCT04218422?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2020-01-22. Estimated completion is 2031-02-20.

What conditions does trial NCT04218422 study?

This clinical trial studies the following conditions: Hidradenitis Suppurativa.

What interventions are being tested in trial NCT04218422?

The interventions under investigation include: Sham Acupuncture (PROCEDURE), Battlefield Acupuncture (PROCEDURE).

Who is sponsoring clinical trial NCT04218422?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04218422 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hidradenitis Suppurativa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.